Soluble intercellular adhesion molecule-1 and soluble E-selectin levels in patients with atopic dermatitis. 1996

S Hirai, and T Kageshita, and T Kimura, and M Tsujisaki, and K Okajima, and K Imai, and T Ono
Department of Dermatology, Kumamoto University School of Medicine, Japan.

The serum levels of soluble intercellular adhesion molecule-1 (sICAM-1) and soluble E-selectin (sE-selectin) were determined by double determinant immunoassay (DDIA), in 37 patients with atopic dermatitis (AD) and 31 age- and sex-matched healthy control subjects. Both sICAM-1 and sE-selectin levels were significantly higher in patients with AD than in healthy controls (P < 0.01), and were correlated with disease severity. A longitudinal study of patients with AD revealed that the levels of sICAM-1 decreased in those in whom symptoms improved. The sICAM-1 levels were significantly correlated with those of sE-selectin. Our studies suggest that such high levels of serum sICAM-1 and sE-selectin may affect the immune response in patients with AD. The levels of sICAM-1 and sE-selectin may be a useful immunological parameter for monitoring disease activity in AD.

UI MeSH Term Description Entries
D008137 Longitudinal Studies Studies in which variables relating to an individual or group of individuals are assessed over a period of time. Bogalusa Heart Study,California Teachers Study,Framingham Heart Study,Jackson Heart Study,Longitudinal Survey,Tuskegee Syphilis Study,Bogalusa Heart Studies,California Teachers Studies,Framingham Heart Studies,Heart Studies, Bogalusa,Heart Studies, Framingham,Heart Studies, Jackson,Heart Study, Bogalusa,Heart Study, Framingham,Heart Study, Jackson,Jackson Heart Studies,Longitudinal Study,Longitudinal Surveys,Studies, Bogalusa Heart,Studies, California Teachers,Studies, Jackson Heart,Studies, Longitudinal,Study, Bogalusa Heart,Study, California Teachers,Study, Longitudinal,Survey, Longitudinal,Surveys, Longitudinal,Syphilis Studies, Tuskegee,Syphilis Study, Tuskegee,Teachers Studies, California,Teachers Study, California,Tuskegee Syphilis Studies
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003876 Dermatitis, Atopic A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema. Eczema, Atopic,Eczema, Infantile,Neurodermatitis, Atopic,Neurodermatitis, Disseminated,Atopic Dermatitis,Atopic Eczema,Atopic Neurodermatitis,Disseminated Neurodermatitis,Infantile Eczema
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012720 Severity of Illness Index Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder. Illness Index Severities,Illness Index Severity

Related Publications

S Hirai, and T Kageshita, and T Kimura, and M Tsujisaki, and K Okajima, and K Imai, and T Ono
October 1994, Journal of dermatological science,
S Hirai, and T Kageshita, and T Kimura, and M Tsujisaki, and K Okajima, and K Imai, and T Ono
January 2009, Lung,
S Hirai, and T Kageshita, and T Kimura, and M Tsujisaki, and K Okajima, and K Imai, and T Ono
September 2000, The Journal of rheumatology,
S Hirai, and T Kageshita, and T Kimura, and M Tsujisaki, and K Okajima, and K Imai, and T Ono
January 1996, Clinical and experimental immunology,
S Hirai, and T Kageshita, and T Kimura, and M Tsujisaki, and K Okajima, and K Imai, and T Ono
February 2005, Coronary artery disease,
S Hirai, and T Kageshita, and T Kimura, and M Tsujisaki, and K Okajima, and K Imai, and T Ono
April 2023, Life (Basel, Switzerland),
S Hirai, and T Kageshita, and T Kimura, and M Tsujisaki, and K Okajima, and K Imai, and T Ono
October 1997, Journal of cardiovascular pharmacology,
S Hirai, and T Kageshita, and T Kimura, and M Tsujisaki, and K Okajima, and K Imai, and T Ono
July 1998, British journal of cancer,
S Hirai, and T Kageshita, and T Kimura, and M Tsujisaki, and K Okajima, and K Imai, and T Ono
January 1997, British journal of cancer,
S Hirai, and T Kageshita, and T Kimura, and M Tsujisaki, and K Okajima, and K Imai, and T Ono
November 2010, Chest,
Copied contents to your clipboard!